AVXL Oct 2022 7.000 put
| Previous close | 1.6500 |
| Open | 1.6500 |
| Bid | 0.3500 |
| Ask | 1.8500 |
| Strike | 7.00 |
| Expiry date | 2022-10-21 |
| Day's range | 1.6500 - 1.6500 |
| Contract range | N/A |
| Volume | |
| Open interest | 512 |
- Motley Fool
Anavex Life Sciences (AVXL) Q3 2022 Earnings Call Transcript
My name is Clint Tomlinson, and I'll be your host for today's call. The call will also be available for replay on Anavex's website at www.anavex.com. With us today is Dr. Christopher Missling, president and chief executive officer; and Sandra Boenisch, principal financial officer.
- GlobeNewswire
Anavex Life Sciences Provides Business Update and Reports Fiscal 2022 Third Quarter Financial Results
Company to host a webcast today at 4:30 p.m. Eastern Time NEW YORK, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal quarter en
- GlobeNewswire
Anavex Life Sciences to Announce Fiscal 2022 Third Quarter Financial Results on Tuesday August 9, 2022
Webcast and Conference Call To be Held Tuesday August 9, 2022, 4:30 pm ETNEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that it will issue financia
